ASHPOfficial

Join us as we dive into 'Race-Based Clinical Calculations Causing Healthcare Disparities,' an essential session from the Midyear Clinical Meeting and Exhibition. We'll explore the reasons this topic matters, actionable steps listeners can take to address these disparities, and the unique benefits of attending Midyear for professional growth. Don't miss out on this critical discussion shaping the future of equitable healthcare!

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The podcast will discuss optimizing the diagnosis, antimicrobial selection, and duration of therapy for adult patients with community-acquired pneumonia admitted to the hospital. This engaging conversation will bring the guidelines to life as an emergency medicine antimicrobial stewardship physician and an infectious diseases clinical pharmacist discuss navigating patients from hospital arrival through admission and how stewardship plays an immediate role in the patient care plan. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this first in a series, Christi Jen and Holly Geyer sit down with Libby Johnson to discuss the creation of an opioid stewardship program, including the identification of key stakeholders, guidelines to follow as well as initial goals for a newly founded opioid stewardship program.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Andrea Sikora and Dr. Brian Murray discuss the AJHP theme issue on critical care pharmacy practice with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Explore the essential contributions of health-system pharmacists through engaging interviews with pharmacists and other healthcare team members who witness their impact firsthand. Nearly one in three pharmacists work beyond retail settings, bringing their specialized expertise in medications to hospitals, clinics, and outpatient facilities. As trusted partners on the healthcare team, these pharmacists work to ensure that medications are safe, effective, and accessible, playing a critical role in each patient’s journey. Listen in as we uncover the many ways pharmacists make a difference. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join ASHP host Cindy Von Heeringen as she discusses the 2025 ASHP Pharmacy Forecast and associated Midyear session with Joe DiPiro (Forecast Editor), Rena Gosser (Advisory Committee member), and James Hoffman (Forecast Deputy Editor).  The 2025 ASHP Pharmacy Forecast will be published in AJHP in December in conjunction with the Midyear session.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast is part of a series unpacking harmful PBM practices. The series will inform listeners about PBMs’ influence over nearly all aspects of patient care and the profession of pharmacy. The series will also identify key resources and strategies enabling pharmacy professionals to engage in effective advocacy efforts to achieve meaningful PBM reform. 

In this episode, we look at the rise of so-called “PBM Group Purchasing Organizations” – affiliated entities recently established by each of the major PBMs. Critics allege that PBM GPOs do not add value to the healthcare system and function solely to enable PBMs to collect excessive profits. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In celebration of Veterans Day 2024, @ASHP Official is highlighting three pharmacist members who volunteered to join the military in service to our Nation. In this episode, we speak with Peter Bulatao, Aaron Middlekauff, and Ryan Lampien about their stories, reflections, and perspectives on how their military experience helped shape their careers, lives, and their sense of paying it forward to provide an inspiration for others. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we discuss the safety and efficacy of administering undiluted levetiracetam via IV push as well as the considerations for incorporating this practice into pharmacy and nursing workflows.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP’s Senior education director, Cindy von Heeringen is joined by Dr. Alex Infante, Clinical Assistant Professor at Texas A&M University  and Dr. Jennie Jarrett, Director of Science and Drug Policy at the American Medical Association as they discuss their upcoming Midyear session that focuses on the ability of pharmacists to use available resources and strategies to positively impact patient care by overcoming barriers in the implementation and utilization of harm reduction services.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.